Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 050579

Expand all

MONOCID (CEFONICID SODIUM)
EQ 500MG BASE/VIAL
Marketing Status: Discontinued

Active Ingredient: CEFONICID SODIUM
Proprietary Name: MONOCID
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 500MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N050579
Product Number: 001
Approval Date: May 23, 1984
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status:  Discontinued
Patent and Exclusivity Information

MONOCID (CEFONICID SODIUM)
EQ 1GM BASE/VIAL
Marketing Status: Discontinued

Active Ingredient: CEFONICID SODIUM
Proprietary Name: MONOCID
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 1GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N050579
Product Number: 002
Approval Date: May 23, 1984
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status:  Discontinued
Patent and Exclusivity Information

MONOCID (CEFONICID SODIUM)
EQ 2GM BASE/VIAL
Marketing Status: Discontinued

Active Ingredient: CEFONICID SODIUM
Proprietary Name: MONOCID
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 2GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N050579
Product Number: 003
Approval Date: May 23, 1984
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status:  Discontinued
Patent and Exclusivity Information

MONOCID (CEFONICID SODIUM)
EQ 10GM BASE/VIAL
Marketing Status: Discontinued

Active Ingredient: CEFONICID SODIUM
Proprietary Name: MONOCID
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 10GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N050579
Product Number: 004
Approval Date: May 23, 1984
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status:  Discontinued
Patent and Exclusivity Information